Shanghai Haixin Group Co Ltd
900917
Company Profile
Business description
Shanghai Haixin Group Co Ltd is a China-based company engaged in the pharmaceuticals business. The Pharmaceutical segment is mainly engaged in the manufacture and sales of pharmaceutical products. Further, it is also involved in financial investment, industrial plant rental management, and textile products business. Geographically, the activities are carried out through China.
Contact
688 Changxing Road
Dongjing Songjiang
Shanghai201619
CHNT: +86 2157698100
Sector
Industrials
Stock type
Sensitive
Industry
Conglomerates
Fiscal Year End
31 December 2025
Employees
715
Stocks News & Analysis
stocks
Potentially catastrophic ruling for ASX company
We raise our risk and uncertainty rating to reflect the impact of the ruling.
stocks
4 charts on Nvidia’s record $4 trillion market cap
Shares of the semiconductor giant have rocketed 280% over the past two years amid the AI boom.
stocks
Could merger breathe new life into struggling ASX asset manager?
Platinum’s board voted unanimously in favour of a merger we expect would be value accretive.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,815.30 | 5.00 | -0.06% |
| CAC 40 | 7,808.17 | 21.12 | -0.27% |
| DAX 40 | 24,165.67 | 89.64 | -0.37% |
| Dow JONES (US) | 44,412.08 | 40.57 | 0.09% |
| FTSE 100 | 8,998.06 | 56.94 | 0.64% |
| HKSE | 24,203.32 | 63.75 | 0.26% |
| NASDAQ | 20,623.63 | 38.11 | 0.19% |
| Nikkei 225 | 39,459.62 | 110.06 | -0.28% |
| NZX 50 Index | 12,678.69 | 7.99 | -0.06% |
| S&P 500 | 6,263.17 | 3.42 | 0.05% |
| S&P/ASX 200 | 8,570.40 | 9.70 | -0.11% |
| SSE Composite Index | 3,519.65 | 9.47 | 0.27% |